Search Result "PCSK9-loss-of-function"

PCSK9 and LDLR The Yin-Yang in the Cellular Uptake of Cholesterol

Journal: Current Hypertension Reviews
Volume: 9 Issue: 4 Year: 2013 Page: 310-323
Author(s): Enrique Morales-Villegas

Recent Patents on PCSK9: A New Target for Treating Hypercholesterolemia

Journal: Recent Patents on DNA & Gene Sequences (DIscontinued)
Volume: 3 Issue: 3 Year: 2009 Page: 201-212
Author(s): Hai Li, Haixia Li, Nick Ziegler, Rutao Cui, Jingwen Liu

Proprotein Convertase Subtilisin Kexin9 (PCSK9): A Novel Target For Cholesterol Regulation

Journal: Protein & Peptide Letters
Volume: 19 Issue: 6 Year: 2012 Page: 575-585
Author(s): Ajoy Basak,Heather Palmer-Smith,Priyambada Mishra

Review Article

Drugs that Mimic the Effect of Gene Mutations for the Prevention or the Treatment of Atherosclerotic Disease: From PCSK9 Inhibition to ANGPTL3 Inactivation

Journal: Current Pharmaceutical Design
Volume: 24 Issue: 31 Year: 2018 Page: 3638-3646
Author(s): Vasilios G. Athyros,Niki Katsiki,Aikaterini Dimakopoulou,Dimitrios Patoulias,Sofia Alataki,Michael Doumas

Review Article

The Role of PCSK9 in Infectious Diseases

Journal: Current Medicinal Chemistry
Volume: 29 Issue: 6 Year: 2022 Page: 1000-1015
Author(s): Laura Magnasco,Chiara Sepulcri,Roberta Maria Antonello,Stefano Di Bella,Laura Labate,Roberto Luzzati,Daniele Roberto Giacobbe,Matteo Bassetti

PCSK9 Inhibition with Evolocumab Reaching Physiologic LDL-C Levels for Reducing Atherosclerotic Burden and Cardiovascular Disease-The Full Landscape

Ebook: Recent Advances in Alzheimer Research
Volume: 4 Year: 2019
Author(s): Enrique C. Morales-Villegas,Kausik K. Ray
Doi: 10.2174/97816810839951180401

Review Article

Treatment with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors to Reduce Cardiovascular Inflammation and Outcomes

Journal: Current Medicinal Chemistry
Volume: 24 Issue: 1 Year: 2017 Page: 1403-1416
Author(s): Luca Liberale,Fabrizio Montecucco,Giovanni G. Camici,Franco Dallegri,Alessandra Vecchie,Federico Carbone,Aldo Bonaventura

Review Article

Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9): Impact of PCSK9 on Major Adverse Cardiac and Cerebrovascular Events

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 14 Issue: 2 Year: 2016 Page: 94-100
Author(s): Muharrem Akin,Thomas Skripuletz,L. Christian Napp,Dominik Berliner,Ibrahim Akin,Arash Haghikia,Elvan Akin,Johann Bauersachs

New Clinical Perspectives of Hypolipidemic Drug Therapy in Severe Hypercholesterolemia

Journal: Current Medicinal Chemistry
Volume: 19 Issue: 28 Year: 2012 Page: 4861-4868
Author(s): C. Stefanutti,C. Morozzi,S. Di Giacomo

Review Article

Pharmacology of PCSK9 Inhibitors: Current Status and Future Perspectives

Journal: Current Pharmaceutical Design
Volume: 24 Issue: 31 Year: 2018 Page: 3622-3633
Author(s): Aikaterini N. Tsouka,Constantinos C. Tellis,Alexandros D. Tselepis

Previous   Next

Go To   Results 1 - 1 of 118

Apply Filters

Volume Years
Article Type
Publication Title
Subject Title

Content Type


© 2025 Bentham Science Publishers | Privacy Policy